Prostate cancer. It is now the second most common form of cancer for men in the United States, according to data from the CDC’s U.S. Cancer Statistics Working Group, with one in nine men being diagnosed with the disease. But what is perhaps even more concerning, is that that prostate cancer is no longer a disease exclusive to older men, as the number of young men diagnosed with the disease has increased six-fold in the last 20 years. The increasing rates of prostate cancer is driving the global market for Prostate Cancer Therapeutics, which is expected to reach $13.1 billion by 2022.
It is likely that nutrient deficiencies from poor diet and less nutrient-rich foods are a factor in this trend. In fact, there is mounting research that nutritional solutions can support prostate health and even reduce incidence and mortality of prostate cancer. Selenium is a primary example. A particularly compelling study in the Journal of the American Medical Association found that 200µg per day of SelenoExcell®, high selenium yeast, supported a 63 percent reduction in prostate cancer and 50 percent overall reduction in cancer mortality. Additional analysis of the study suggested that the results were most pronounced in men with lower baseline blood selenium levels, a lower PSA and in younger men.
The body of research is so significant that the FDA has even approved a qualified health claim for products that contain selenium regarding a reduction in the risk of certain cancers and selenium’s anti-carcinogenic effects in the body.